Novo Nordisk A/S Common Stock (NVO)
Deferred Revenue
kr 0.00
Quarterly · Period ending: · DKK

NVO Deferred Revenue
Latest reportedkr 0.00 DKKperiod ending
Latest reportedkr 0.00 DKKperiod ending
NVO Quarterly Deferred Revenue · DKK (kr 0.00 → kr 0.00)
Quarterly deferred revenue
High-resolution chart · PNG
NVO deferred revenue history
Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (DKK) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 39,545,000,000 | |
| 35,325,000,000 | |
| 32,431,000,000 | |
| 44,869,000,000 | |
| 29,296,000,000 | |
| 28,128,000,000 | |
| 24,104,000,000 | |
| 39,443,000,000 | |
| 26,458,000,000 | |
| 23,576,000,000 | |
| 26,215,000,000 | |
| 38,618,000,000 | |
| 23,225,000,000 | |
| 21,704,000,000 | |
| 21,425,000,000 | |
| 33,491,000,000 | |
| 20,032,000,000 | |
| 18,736,000,000 | |
| 17,280,000,000 | |
| 25,412,000,000 | |
| 14,030,000,000 | |
| 10,237,000,000 | |
| 10,432,000,000 | |
| 2,983,000,000 | |
| 12,721,000,000 | |
| 12,022,000,000 | |
| 10,822,000,000 | |
| 17,231,000,000 | |
| 13,218,000,000 | |
| 10,781,000,000 | |
| 9,302,000,000 | |
| 7,111,000,000 | |
| 8,160,000,000 | |
| 7,680,000,000 | |
| 6,613,000,000 | |
| 5,896,000,000 | |
| 1,271,000,000 | |
| 613,000,000 | |
| 661,000,000 | |
| 701,000,000 | |
| 1,133,000,000 | |
| 755,000,000 | |
| 3,390,000,000 | |
| 80,238,000 | |
| 0 | |
| 0 | |
| 0 | |
| 122,736,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 109,756,200 | |
| 0 | |
| 0 | |
| 0 | |
| 810,039,900 | |
| 1,323,528,030 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |